The majority of analyst ratings for TransMedics Gr (TMDX) in the last quarter are positive, with 2 bullish and 4 somewhat bullish ratings. The average 12-month price target has increased by 13.45% from the previous average, indicating a positive outlook for the stock. This information is important for investors as it shows that analysts have a favorable view of the company's prospects, which could lead to an increase in stock price.